However, our NSCLC validation cohort showed that rs3212986, a 3 prime UTR variant of ERCC1, was associated with a higher risk of cisplatin-induced nephrotoxicity, a result that was in line with previous studies [47,48]. Here, ERCC1 is linked to non-small cell lung carcinoma.